




Searching News Database: ProGuard
HSMN NewsFeed - 28 Apr 2014
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
Cyberonics Names Rohan Hoare, Ph.D. Chief Operating Officer And O'Neill D'Cruz, M.D. Chief Medical Officer
HSMN NewsFeed - 14 Nov 2006
Kensey Nash Announces Commencement of Carotid Pivotal Trial for TriActiv ProGuard System
Kensey Nash Announces Commencement of Carotid Pivotal Trial for TriActiv ProGuard System
HSMN NewsFeed - 23 Oct 2006
Kensey Nash Receives CE Mark Approval for New ThromCat(TM) Thrombectomy Catheter System
Kensey Nash Receives CE Mark Approval for New ThromCat(TM) Thrombectomy Catheter System
HSMN NewsFeed - 12 Jul 2006
Kensey Nash Receives FDA 510(k) Clearance for TriActiv FX(R) Embolic Protection System
Kensey Nash Receives FDA 510(k) Clearance for TriActiv FX(R) Embolic Protection System
HSMN NewsFeed - 26 May 2006
Kensey Nash Announces Acquisition of Assets of IntraLuminal Therapeutics, Inc.
Kensey Nash Announces Acquisition of Assets of IntraLuminal Therapeutics, Inc.
HSMN NewsFeed - 27 Apr 2006
Kensey Nash Receives FDA 510(k) Clearance for New ThromCat(TM) Thrombectomy Catheter System
Kensey Nash Receives FDA 510(k) Clearance for New ThromCat(TM) Thrombectomy Catheter System
HSMN NewsFeed - 26 Apr 2006
Kensey Nash Announces Completion of Carotid Pilot Trial Using the TriActiv(R) ProGuard(TM) System
Kensey Nash Announces Completion of Carotid Pilot Trial Using the TriActiv(R) ProGuard(TM) System
HSMN NewsFeed - 31 Mar 2006
Hypoguard Receives 510(k) Clearance to Market Assure(R) Pro Blood Glucose Monitoring System
Hypoguard Receives 510(k) Clearance to Market Assure(R) Pro Blood Glucose Monitoring System
HSMN NewsFeed - 10 Mar 2006
Kensey Nash Receives FDA 510(k) Clearance for QuickCat(TM) Extraction Catheter
Kensey Nash Receives FDA 510(k) Clearance for QuickCat(TM) Extraction Catheter
HSMN NewsFeed - 7 Mar 2006
Kensey Nash Announces Low 3.2% MACE Rate Achieved Using New TriActiv FX(R) Embolic Protection System
Kensey Nash Announces Low 3.2% MACE Rate Achieved Using New TriActiv FX(R) Embolic Protection System
HSMN NewsFeed - 15 Feb 2006
Kensey Nash Receives CE Mark Approval for New TriActiv(R) ProGuard(TM) Embolic Protection System
Kensey Nash Receives CE Mark Approval for New TriActiv(R) ProGuard(TM) Embolic Protection System
HSMN NewsFeed - 23 Jan 2006
Kensey Nash Submits TriActiv FX(R) Embolic Protection System 510(k) Application to FDA
Kensey Nash Submits TriActiv FX(R) Embolic Protection System 510(k) Application to FDA
HSMN NewsFeed - 12 Jan 2006
Kensey Nash Submits QuickCat(TM) Extraction Catheter 510(k) Application to FDA
Kensey Nash Submits QuickCat(TM) Extraction Catheter 510(k) Application to FDA
Additional items found! 2

Members Archive contains
2 additional stories matching:
ProGuard
(Password required)
ProGuard
(Password required)